Influenza activity — United states, 2014–15 season and composition of the 2015–16 influenza vaccine

Morbidity and Mortality Weekly Report

Volumn 64, Issue 21, 2015, Pages 583-590

  Appiah, G Race D ^a   Blanton, Lenee ^a   D’Mello, Tiffany ^a   Kniss, Krista ^a   Smith, Sophie ^a   Mustaquim, Desiree ^a   Steffens, Craig ^a   Dhara, Rosaline ^a   Cohen, Jessica ^a   Chaves, Sandra S ^a   Bresee, Joseph ^a   Wallis, Teresa ^a   Xu, Xiyan ^a   Elal, Anwar Isa Abd ^a   Gubareva, Larisa ^a   Wentworth, David E ^a   Katz, Jacqueline ^a   Jernigan, Daniel ^a   Brammer, Lynnette ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; CHEMISTRY; CHILD; CHILDHOOD MORTALITY; GENETIC VARIABILITY; GENETICS; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; MORTALITY; OUTPATIENT; PNEUMONIA; PRESCHOOL CHILD; SEASON; STATISTICS AND NUMERICAL DATA; UNITED STATES; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; GENETIC VARIATION; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; OUTPATIENTS; PNEUMONIA; POPULATION SURVEILLANCE; SEASONS; UNITED STATES; YOUNG ADULT;

EID: 84931082545     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Flannery B, Clippard J, Zimmerman RK, et al. Early estimates of seasonal influenza vaccine effectiveness—United States, January 2015. MMWR Morb Mortal Wkly Rep 2015;64:10–5.
2. Food and Drug Administration. March 4, 2015: Vaccines and Related Biological Products Advisory Committee meeting summary minutes. Silver Spring, MD: Food and Drug Administration; 2015. Available at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM438843.pdf.
3. CDC. FluView interactive. Available at http://www.cdc.gov/flu/weekly/fluviewinteractive.htm.
4. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333–40.
5. CDC. Estimates of deaths associated with seasonal influenza—United States, 1976–2007. MMWR Morb Mortal Wkly Rep 2010;59:1057–62.
6. CDC. Health advisory regarding the potential for circulation of drifted influenza A (H3N2) viruses. Available at http://emergency.cdc.gov/HAN/han00374.asp.
7. CDC. CDC presents updated estimates of flu vaccine effectiveness for the 2014–2015 season. Available at http://www.cdc.gov/flu/news/updated-vaccine-effectiveness-2014-15.htm.
8. Rolfes M, Blanton L, Brammer L, et al. Update: influenza activity— United States, September 28–December 6, 2014. MMWR Morb Mortal Wkly Rep 2014;63:1189–94.
9. D’Mello T, Brammer L, Blanton L, et al. Update: influenza activity— United States, September 28, 2014–February 21, 2015. MMWR Morb Mortal Wkly Rep 2015;64:206–12.
10. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza— recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(No. RR-1).